In addition, in the univariate analysis, we observed a significant and positive correlation between PHGDH gene expression and predicted or measured trametinib response across our six GBM datasets (five patient cohorts and avatar) (Supplemental Figure S5). This evidence concerns the gene PHGDH and glioblastoma.